FIGURE 2.

Disease characteristics and probability of receiving intensive second‐line treatment and going through autologous stem cell transplantation. (A) Associations between disease characteristics and probability of receiving intensive second‐line treatment among patients with relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) of at most 70 years of age, estimated using multivariable logistic regression [odds ratios and 95% confidence intervals (CI)]. (B) Associations between disease characteristics and probability of going through ASCT after intensive treatment, among patients with relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) of at most 70 years of age, estimated using Cox regression (hazard ratios, 95% CI). CCI, Charlson comorbidity index; ECOG, Eastern Cooperative Oncology Group; IPI, international prognostic index; LDH, lactate dehydrogenase